XLXuan Li

Xuan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuan Li has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Temporal drift, calibration monitoring, and adaptive updating of an IVIG resistance prediction model in Kawasaki disease: a multicenter pediatric cohort study

    by Hongbiao Huang, Ying He, Jiaying Zhang, Jinfeng Dong, Fan Lin, Chengyi Wang, Zhenxin Xu, Qiaobin Chen, Lizhi Li, Xin Zheng, et al.

  • Development and Validation of an Interpretable Prediction Model for IVIG‐Resistant Kawasaki Disease: A Multicenter Prospective Cohort Study

    by Shuhui Wang, Zhiyuan Liu, Miao Hou, Ling Sun, Yunjia Tang, Xuan Li, Ye Chen, Yongmao Xu, Qin Shen, Sheng Zhao, et al.

    Background: Early identification of intravenous immunoglobulin‐resistant Kawasaki disease is important for reducing the risk of coronary artery lesions. We aimed to develop, externally validate, and deploy an interpretable machine‐learning model for early prediction of intravenous immunoglobulin‐resistant Kawasaki disease. Methods: The derivation cohort included 3023 patients with Kawasaki disease admitted to Children's Hospital of Soochow University from January 2020 to December 2024 and was used for model training and internal validation. External validation included 1632 patients from 3 independent hospitals during the same period. Thirty‐three clinical variables available within 24 hours of admission were used to develop 12 machine‐learning models. Model discrimination was assessed using the area under the curve, and Shapley Additive Explanations were used for model interpretation. Results: Among the 12 algorithms, the Extra Trees model showed the best discriminative performance. After feature reduction, an interpretable Extra Trees model incorporating 8 variables was selected. The model achieved area under the curve of 0.865 in internal validation, 0.890 in the Anhui cohort (n=654), 0.805 in the Xuzhou cohort (n=574), and 0.853 in the Suqian cohort (n=404). The final model was implemented as a web‐based application for individualized risk estimation. Conclusions: We developed and externally validated an interpretable machine‐learning model for early prediction of intravenous immunoglobulin‐resistant Kawasaki disease. Shapley Additive Explanations‐based interpretation and web deployment may facilitate individualized risk assessment and clinical decision‐making.

  • Open Access

    Radiofrequency Catheter Ablation for Arrhythmia-induced Cardiomyopathy in Infants: A Case Series and Literature Review

    by Xuan Li, Wenjuan Shu, Miao Hou, Haitao Lv, Qiuqin Xu, Bo Wang, Ling Sun, Jiajia Tan, Ye Chen, Wanping Zhou

    Radiofrequency catheter ablation (RFCA) is an established treatment for paediatric arrhythmias in children weighing >15 kg, yet its role in infants with arrhythmia-induced cardiomyopathy remains less defined. This case series evaluates the efficacy and safety of RFCA in four infants (aged ≤1 year) with arrhythmia-induced cardiomyopathy through a retrospective review of clinical profiles, procedural data and outcomes. All patients had right-sided accessory pathways, with three showing atrioventricular re-entrant tachycardia and one pre-excitation-related cardiomyopathy. Each infant had failed pharmacotherapy, and presented with heart failure and cardiac enlargement. RFCA was successfully performed in all cases without complications. Within 1–6 months postprocedure, both cardiac function and size normalised in every patient. These findings support RFCA as a safe and effective treatment for medically refractory, right-sided, pathway-mediated, arrhythmia-induced cardiomyopathy in infants, highlighting its potential for complete functional recovery.

  • An assessment of neutrophil percentage‑to‑albumin ratio in Kawasaki disease

    by Yunjia Tang, Jiaying Zhang, Xuan Li, Jin Ma, Wanping Zhou, Haitao Lv

    Kawasaki disease (KD) is an immune vasculitis of unknown etiology. Coronary artery lesions (CALs) and intravenous immunoglobulin resistance (IVIGR) are two major clinical challenges in KD. Previous studies had pointed out that neutrophil percentage‑to‑albumin ratio (NPAR) was associated with the prognosis of cardiac diseases. However, its role in KD has not been fully explored. We enrolled patients with the main diagnosis of KD admitted to Children's Hospital of Soochow University between December 2018 and June 2024. Patients were stratified into tertiles based on NPAR, and comparisons among groups were conducted. Univariate and multivariable logistic regression were carried out. Restricted cubic splines and fitted curves were used to examine the relationships between NPAR and the presence of CALs and IVIGR. Subgroup analyses were also investigated. A total of 2371 patients were included in the present study. The incidences of IVIGR and CALs were 12.9% (305/2371) and 28.3% (670/2371), respectively. Patients with higher NPAR levels exhibited higher incidences of IVIGR. In contrast, NPAR was not associated with CALs. A positive linear relationship was noted between NPAR and IVIGR (p < 0.001). The expected presence of IVIGR was also positively related to NPAR. However, the association was modified by age and coronary artery status. NPAR may serve as a prognostic indicator for IVIGR, particularly in patients younger than 48 months and those without CALs, but not for CALs.

  • Open Access

    Protective Effects of Jiawei Baihu Tang in Kawasaki Disease: Omics Analysis and Mechanistic Exploration

    by Jin Ma, Xiudao Song, Xuan Li, Yunjia Tang, Haitao Lv, Yexing Chen, Peng Cao

    Kawasaki disease (KD) is classified as a "WenBing" syndrome in traditional Chinese medicine (TCM), characterized by systemic inflammation and vasculitis. Jiawei Baihu Tang (JWBHT) is an optimized herbal formulation derived from the classical Baihu Tang (BHT), a renowned ancient TCM prescription traditionally used to treat WenBing syndromes by clearing heat, reducing fever, and promoting body fluid production. However, the precise pharmacological mechanisms underlying JWBHT's intervention effects remain largely unexplored. We aimed to assess the protective effects of JWBHT on coronary artery inflammation in mice with KD and explore the underlying mechanisms, with a focus on the lipocalin-2/matrix metalloproteinase 9 (LCN2/MMP9) axis in vascular remodeling. Histopathological analysis, multiplex immunofluorescence, data-independent acquisition (DIA) proteomics, and non-targeted metabolomics were employed to comprehensively measure the effects of JWBHT on coronary artery injury. The experiments were conducted using a Candida albicans water-soluble fraction (CAWS)-induced murine model of KD vasculitis. Multi-omics integration also revealed the role of JWBHT in regulating extracellular matrix (ECM)-receptor interaction and enhancing α-linolenic acid metabolism. JWBHT significantly alleviated coronary arteritis by reducing inflammatory cell infiltration, preserving ECM integrity, and alleviating fibrosis. Multi-omics analysis indicated that JWBHT regulated ECM-receptor interaction and restored lipid metabolism, particularly α-linolenic acid metabolism, which was closely linked to ECM stabilization. Mechanistically, JWBHT suppressed the LCN2/MMP9 axis, a critical mediator of vascular remodeling. Validation based on the clinical dataset revealed elevated levels of LCN2/MMP9 in patients with acute KD, which were normalized after treatment. For the first time, this study unveiled the multi-target mode of action of JWBHT in KD through the crosstalk between ECM and lipid metabolism, and LCN2 was identified as a potential novel intervention target. Our findings suggest that JWBHT is a promising traditional Chinese medicine for preventing the cardiovascular complications of KD.

  • A Cohort Study on Prognostic Factors for Long-Term Success after Catheter Ablation of Supraventricular Tachycardia in Children

    by Wanping Zhou, Yiyi Shen, Changqing Tang, Ye Chen, Ling Sun, Lei Cao, Jie Shen, Yunjia Tang, Ye Wang, Haitao Lv, et al.

    Introduction: Radiofrequency catheter ablation (RFCA) is an established therapy for pediatric supraventricular tachycardia (SVT). However, data on long-term outcomes and predictors of success from sizable contemporary cohorts are limited. This study aimed to evaluate the long-term clinical success rate of RFCA in a pediatric cohort and to identify independent predictors of arrhythmia-free survival. Methods: We conducted a retrospective analysis of 219 consecutive pediatric patients (age ≤18 years) who underwent their first RFCA for SVT (including atrioventricular reentrant tachycardia, atrioventricular nodal reentrant tachycardia, and atrial tachycardia) at a single tertiary center over a 6-year period. The primary outcome was long-term clinical success, defined as acute procedural success without clinical recurrence during follow-up. Univariable and multivariable logistic regression analyses were performed to identify factors associated with long-term success. Results: The overall acute procedural success rate was 96.3% (211/219, excluding 3 with non-inducible SVT and 5 acute failures from the denominator). The long-term clinical success rate was 91.3% (based on 200/219 patients). Multivariable analysis identified older age as a significant independent predictor of long-term success (p = 0.016). Furthermore, atrial tachycardia was associated with a lower odd of success compared to atrioventricular nodal reentrant tachycardia, although the difference was not statistically significant. Conclusion: RFCA is highly effective for treating pediatric SVT, with excellent long-term durability. Older age at procedure is a strong independent predictor of success, while patients with AT may have a higher risk of recurrence. These findings are valuable for pre-procedural counseling and patient selection.


  • Gastrointestinal Presentation at Onset or After Initial Treatment in Kawasaki Disease

    by Yunyi Zhu, Zhiheng Liu, Guanghui Qian, Wanping Zhou, Weiguo Qian, Haitao Lv, Xuan Li

    Kawasaki disease (KD) is an acute febrile illness that was recognized as the most common acquired cardiovascular disease among children. Recent years have witnessed a progressive increase in the proportion of cases diagnosed with incomplete KD owing to atypical clinical presentation. The typical reported gastrointestinal symptoms in these patients include diarrhea, vomiting, abdominal pain, hepatitis, gallbladder hydrops, and pancreatitis. This study reviewed 4 patients with KD at our hospital, who presented with acute abdomen. The presence of atypical symptoms such as gastrointestinal symptoms tends to obviate the other manifestations of KD, which may lead to misdiagnosis of acute abdomen and inappropriate surgical treatment. As illustrated in this case series, these children have clinical symptoms or signs suggestive of KD (especially lymphadenopathy or rash) early in the disease course that are liable to be missed or overlooked.

  • Open Access

    Circulating PGRN Levels Are Increased but Not Associated with Insulin Sensitivity or β-Cell Function in Chinese Obese Children

    by Fengyun Wang, Ting Chen, Ling Sun, Haitao Lv, Xuan Li, Jie Shen, Linqi Chen, Zhenyu Chu, Miao Hou

    Progranulin (PGRN), a novel peptide that has recently emerged as an important regulatory adipokine, is relevant to energy homeostasis and obesity in animals and adult humans. Little is known about its roles in children. The aim of the current study was to determine the potential role of PGRN and explore its relationship to various obesity-related markers in obese children. This was a cross-sectional study composed of 77 children (43 obese and 34 healthy, age 8.68 ± 0.28 and 8.46 ± 0.45 years, resp.). The PGRN levels were significantly higher in obese children (102.44 ± 4.18 ng/mL) comparing to controls (69.32 ± 5.49 ng/mL) (P<0.05). Moreover, the PGRN levels were positively correlated with triglyceride (TG), total cholesterol (TC), IL-6, systolic blood pressure (SBP), and diastolic blood pressure (DBP) in obese children after adjusted for BMI and age. However, there was no correlation of serum PGRN levels with OGTT-derived dynamic parameters, HOMA-IR, or HOMA-β in obese children. The results suggest that serum PGRN levels are significantly higher in obese children in China and correlate significantly with obesity-related markers. Increased PGRN levels may be involved in the pathological mechanism of childhood obesity.